← All organizations

Sirna Therapeutics

For profit

Also known as: Ribozyome | Sirna Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 1, 2004

Acquired by Merck on Jan 1, 2006

Timeline

1990s

Jan 1, 1992
Sirna Therapeutics— Founded

2000s

Jan 1, 2006
Merck— Acquired By

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

NCT00363714CollaboratorPhase 1/Phase 2Nov 1, 2004
NCT00021021Lead sponsorPhase 2Sep 1, 2001
NCT00002221Lead sponsorPhase 2Nov 2, 1999

Details

Founded: San Francisco, CA, US Jan 1, 1992
Last known activity: Nov 1, 2004